Monthly information on share capital and company voting rights

PARIS, Sept. 03, 2025 (GLOBE NEWSWIRE) --

(Article 223-16 of General Regulation of the French financial markets authority)

Listing market: Euronext Growth

ISIN code: FR0010425595

For further information on Cellectis, please contact: 
Media contacts:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, [email protected]
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, [email protected] 

Attachment

• Voting_Rights_PR_August_2025_EN

You May Also Be Interested In

• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
• The Apex Institute Reveals What Hiring Managers Actually Want in Cloud and AI Infrastructure Roles
• Air Today Heating & Cooling Named South Carolina’s Best HVAC Sales and Service Company for the Second Year in a Row